NJIM
PFE icon

Nabity-Jensen Investment Management’s Pfizer PFE Stock Holding History

Nabity-Jensen Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,141
Closed -$229K – 73
2026
Q1 		$229K Buy
8,141
+26
+0.3% +$692 0.16% 70
2025
Q4 		$202K Buy
8,115
+91
+1% +$2.29K 0.14% 70
2025
Q3 		$204K Sell
8,024
-2,564
-24% -$63.3K 0.14% 69
2025
Q2 		$257K Sell
10,588
-1,497
-12% -$34.9K 0.19% 62
2025
Q1 		$306K Buy
12,085
+100
+0.8% +$2.62K 0.24% 58
2024
Q4 		$318K Hold
11,985
– – 0.24% 56
2024
Q3 		$347K Hold
11,985
– – 0.27% 54
2024
Q2 		$335K Sell
11,985
-400
-3% -$11K 0.27% 53
2024
Q1 		$344K Sell
12,385
-821
-6% -$22.8K 0.28% 51
2023
Q4 		$380K Buy
+13,206
New +$399K 0.34% 47

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nabity-Jensen Investment Management's PFE Position: Q2 2026 in Review

Nabity-Jensen Investment Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,141 shares — an estimated $229K sold.

Nabity-Jensen Investment Management first reported a position in PFE in Q4 2023 and held it in 10 quarters. The position peaked at $380K in Q4 2023. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Nabity-Jensen Investment Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Nabity-Jensen Investment Management sold 8,141 Pfizer shares in Q2 2026, an estimated $229K.
  • Nabity-Jensen Investment Management first reported a position in Pfizer in Q4 2023 and held it in 10 quarters.
  • Nabity-Jensen Investment Management's Pfizer position peaked at $380K in Q4 2023.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nabity-Jensen Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.